Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery

Arylamine N-acetyltransferases (NATs) are polymorphic drug-metabolizing enzymes, acetylating arylamine carcinogens and drugs including hydralazine and sulphonamides. The slow NAT phenotype increases susceptibility to hydralazine and isoniazid toxicity and to occupational bladder cancer. The two poly...

Descripción completa

Detalles Bibliográficos
Autores principales: Sim, E, Abuhammad, A, Ryan, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158862/
https://www.ncbi.nlm.nih.gov/pubmed/24467436
http://dx.doi.org/10.1111/bph.12598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158862/
https://www.ncbi.nlm.nih.gov/pubmed/24467436
http://dx.doi.org/10.1111/bph.12598

Ejemplares similares